Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Clinical trial NCT02579863 · TERMINATED
Trial details
- NCT number
- NCT02579863
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-19
- Primary completion
- 2018-07-09
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.